YM

Yaseen Mohd Khaja Mohiuddin

Active Director Director DIN 11105900
DIN 11105900 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Yaseen Mohd Khaja Mohiuddin

Data last updated:

Yaseen Mohd Khaja Mohiuddin is a Director at Shams India Pharmaceutical Private Limited (since 2025). The company operates in Pharma.

DIN 11105900
Primary Designation Director
Industry Pharma
First Appointment 14 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 May 20252025Active

Board colleagues of Yaseen Mohd Khaja Mohiuddin

NameDINCompanyDesignation
Saleha Begum11105899Shams India Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shams India Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Yaseen Mohd Khaja Mohiuddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yaseen Mohd Khaja Mohiuddin

Yaseen Mohd Khaja Mohiuddin currently holds 1 directorship: Shams India Pharmaceutical Private Limited (Director, since 14 May 2025).

Yaseen Mohd Khaja Mohiuddin was first appointed on 14 May 2025 as Director at Shams India Pharmaceutical Private Limited.

The current boards of Yaseen Mohd Khaja Mohiuddin's companies include Saleha Begum (Shams India Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available